<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by David Shifrin on Medium]]></title>
        <description><![CDATA[Stories by David Shifrin on Medium]]></description>
        <link>https://medium.com/@dshifrin?source=rss-d2e3b011f3eb------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*3fb7Y6nBcPna2oE3DLswbQ.jpeg</url>
            <title>Stories by David Shifrin on Medium</title>
            <link>https://medium.com/@dshifrin?source=rss-d2e3b011f3eb------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 03:56:53 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@dshifrin/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Healthy Optimism — September 15]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-september-15-e701737faa19?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/e701737faa19</guid>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[innovation]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Sat, 16 Sep 2017 02:16:47 GMT</pubDate>
            <atom:updated>2017-09-16T02:16:47.018Z</atom:updated>
            <content:encoded><![CDATA[<h3>Incremental change</h3><p>Remember that thing where you’re supposed to give up one of your weekly coffees and put the $5 towards retirement or something like that? If the old-school financial bloggers are to believed (and really, who wouldn’t believe them?), it’s supposed to be the difference between driving a ’92 Ford Taurus and living in an extended-stay motel during retirement versus owning the Ford dealership and having to pick between the mountain house or the beach house.</p><p>Ok, so uh, it turns out that $5 a week over 30 years with an average annual return mirroring historical stock numbers isn’t going to buy you a place in Aspen. It’ll get you a simple but decent car (see the handy Morningstar calculator below for proof).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/996/1*I76kMVSvYEpRJnWOrbWkWg.png" /></figure><p>But maybe — ok, probably — I misunderstood the intent behind that advice. It’s not the $5 that matters, it’s the incremental behavioral change of saying no to some thing AND the incremental change building a habit of “finding” extra money to save. Once I’ve figured out how to consistently save $5 a week, I can build on it.</p><p>Point is, incremental change matters. We should talk more about incremental change in health. We should be more excited about about incremental change. Not everything has to be “revolutionary.” Innovation can be incremental. Behavioral change can be incremental and still make a difference.</p><p>Rasu Shrestha, Chief Innovation Officer at University of Pittsburgh Medical Center, pointed this out on the <a href="https://itunes.apple.com/us/podcast/making-empty-hospital-beds-ok-rasu-shrestha-upmc/id1243930008?i=1000391854733&amp;mt=2">podcast</a> in talking about the existing healthcare system:</p><p>“A subtle 2 degree, 5 degree shift could in the long run make a remarkable difference with regards to whether you hit that iceberg and, you know, capsize that ship or not.</p><p>“The 2, 3 degree, 5 degree nudges that we’re talking about [are] how we’re making decisions, and at the end of the day that’s what innovation really is about. It’s making sure that you’re able to affect behavior change.”</p><p>Unlike one person saving only $5 a week, a series of 2 degree shifts propagated across entire hospital systems or patient populations will make a huge difference over time. In the case of health (instead of healthcare), those incremental changes could be the difference between staying healthy and hospitalizations or readmissions. Over time, as populations collectively make incremental changes (let’s go with the lazy examples of eating an extra serving of vegetables and walking slightly more), those habits will be propagated across the community and down to new generations. Behavioral evolution.</p><p>Sometimes it’s not slight changes in behavior but in productivity. Maybe because of new technology, maybe rearranging existing methods.</p><p>Health:Further 2017 pitch competition winner <a href="http://twiagemed.com/">Twiage</a> saves time for emergency medical personnel in two ways. One is truly incremental, getting the patient’s information from the ambulance to the receiving hospital quicker than current standards:</p><p>“If there’s a patient out there that’s having a heart attack or stroke, every second counts for that patient.”</p><p>The second time saver from Twiage is not incremental. According to Co-Founder YiDing Yu, the company’s platform can cut ambulance turnaround times by as much as 65%. Cutting something by more than half does not qualify as incremental, so I’ll leave that side of things alone.</p><p>With a heart attack or stroke, though, a few seconds — incremental in realtime terms — has the potential to be everything for the patient. Saving seconds is everything. Of course, the turnaround time is also significant for the same reason, just more dramatic.</p><p>So here, it’s not behavior but simply increased efficiency, giving a few added moments bak where it matters.</p><p>Why am I bringing this all up? I guess what it comes down to is I’m kinda tired of everything that’s put in front of us being pitched as the next big thing. Look, I get it. I’m heavily involved in the marketing here at Health:Further and understand the need to catch people’s attention. Still, it gets old when EVERYTHING is turned into the most amazing thing ever. If everything is The Greatest, nothing is.</p><p>I think Coke has it right: Instead of making a big deal out of switching from Coke Zero (I’m going to be mourning that loss for a while, btw) to Coke Zero Sugar, they kept things calm. Which is good, because the new product <a href="http://adage.com/article/cmo-strategy/coke-zero-rebrand-coca-cola-zero-sugar-marketing/309923/">isn’t really all that different</a> from Coke Zero. It’s incremental.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fge4DT9RJICQ%3Ffeature%3Doembed&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dge4DT9RJICQ&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2Fge4DT9RJICQ%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/fddc517fd1a43a684d5c83aca4f62a54/href">https://medium.com/media/fddc517fd1a43a684d5c83aca4f62a54/href</a></iframe><p>Great! Let’s treat things as they are, especially when it comes to internal conversations within the health community. If there’s a new product that does something useful and can help turn the Titanic by 2 degrees, put it out there and celebrate it for what it does, not try to make it more than it is.</p><p>There’s nothing wrong with incremental. Not everything can change the world dramatically. Let’s not pretend otherwise.</p><p>I’d also argue that it’s especially important when it comes to health products. As Elisabeth Rosenthal points out in her powerful book <a href="https://www.amazon.com/American-Sickness-Healthcare-Became-Business/dp/1594206759/"><em>An American Sickness</em></a>, in many cases the FDA doesn’t require new drugs or devices to demonstrate superiority over existing products on the market as part of the approval process. Has that gotten the healthcare industry in the habit of overstating the newest thing, or is it just a product of human nature — we all want to make things as big and exciting as possible? Probably the latter if I’m being fair.</p><p>Either way, everyone who touches a product that affects our health needs to know what it is. Whether it’s clearly defining what “organic” food is, or laying out exactly how a health app can (and can’t) improve interactions between a patient and provider, or understanding the relative benefits of a newly approved drug, the producers of those products — I think — need to back off the hype machine.</p><p>Even small gains matter, so let’s own them, and work to aggregate them into massive change over time and distance. $5 might not buy a new Tesla, but once we’re in the habit of saving that much, we can make it $10, then $15…</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e701737faa19" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-september-15-e701737faa19">Healthy Optimism — September 15</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism, July 12 2017]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-july-12-2017-16b096e0ef96?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/16b096e0ef96</guid>
            <category><![CDATA[tribute]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[cancer]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 12 Jul 2017 20:04:43 GMT</pubDate>
            <atom:updated>2017-07-12T20:45:32.623Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3qo0MLoT_Vt10PSWhpSYPQ.png" /></figure><h3>Neal Patterson</h3><p>We at Health:Further, like the rest of the healthcare community, were deeply saddened to hear about the passing of Neal Patterson, CEO of Cerner, due to unexpected complications from cancer.</p><p>To be clear, I didn’t know Patterson. We have a lot of great contacts at Cerner. What I do know from those contacts is that it was a very tough loss for the team there.</p><p>Something that struck me in reading the coverage of Patterson’s passing was <a href="https://blogs.cerner.com/blog/passing-of-neal-patterson/">this comment</a> from Co-Founder and Vice Chairman of the Board (and now chairman and interim CEO) Cliff Illig:</p><blockquote>“One of Neal’s enduring ambitions for Cerner was to build a visionary company, not just a company with a visionary”</blockquote><p>That is an impressive, and incredibly difficult thing to do. We see so many companies with visionary founders that can’t maintain their edge after loss of that original leader. Time will tell at Cerner, but we can hope that Illig’s comments are born out and the culture built largely by Patterson allows for many years of continued innovation.</p><p>But of course, the revenue and corporate success is just business. More important is the “why” behind the culture. In Patterson’s case, it was a life of integrity and incredibly hard work, pushing to create a great result for everything he was involved in and caring for the people involved. And that’s why the people at Cerner are so deeply affected by the loss of their leader.</p><p>On top of that is the effect Patterson’s passing will have on his personal community. I won’t even begin to speak to that other than to repeat our condolences.</p><p>Also, cancer sucks.</p><p>We look at the numbers and are encouraged to see the s<a href="https://www.cancer.gov/about-cancer/understanding/statistics">ignificant drop in cancer deaths over the past 25 years or so</a>. And that’s a very good thing. But that still leaves the horror of losing individual people to cancer. Generic stats mean nothing when it happens to someone we know. I’ve dealt with it, I’m watching close friends currently fighting it, and I think that holds true for just about all of us.</p><p>Here is yet another reminder that saying we’re going to “cure cancer” is a good thing to say but not really a real thing. Mostly because it’s not one disease. It’s a huge group of diverse diseases with different etiologies that affect individuals differently depending on genetics, environment and lifestyle. We have made incredible, wonderful progress in understanding how these diseases work. And we have a very long way to go.</p><p>So here’s to the memory of Neal Patterson. Here’s encouragement to anyone dealing with any type of cancer, keep fighting. And here’s a huge shout out to the researchers and clinicians working so hard on the almost unbelievable task of understanding, preventing and treating the horror of cancer.</p><p>More from Cerner:</p><ul><li><a href="https://blogs.cerner.com/blog/passing-of-neal-patterson/">News release</a></li><li><a href="https://blogs.cerner.com/blog/neal-patterson-obituary/">Obituary</a></li><li><a href="https://www.cerner.com/">Homepage tribute</a></li><li><a href="https://www.cerner.com/pages/neal-patterson">Memorial page</a></li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=16b096e0ef96" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-july-12-2017-16b096e0ef96">Healthy Optimism, July 12 2017</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[David Vivero | Amino | Meeting People Where They Are]]></title>
            <link>https://medium.com/healthfurther/the-future-of-health-ep-7-d264882d2346?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/d264882d2346</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[patient-engagement]]></category>
            <category><![CDATA[consumer-engagement]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[future-of-health]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Thu, 22 Jun 2017 14:07:17 GMT</pubDate>
            <atom:updated>2017-07-11T11:34:44.302Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*epqfEP-MrvcLRI3CfspgjQ.png" /></figure><h3>The Future of Health, Ep. 7, 8</h3><p>Part 1:</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fw.soundcloud.com%2Fplayer%2F%3Furl%3Dhttp%253A%252F%252Fapi.soundcloud.com%252Ftracks%252F328974478%26show_artwork%3Dtrue&amp;url=https%3A%2F%2Fsoundcloud.com%2Fuser-119048141%2Fdavid-vivero-amino-meeting&amp;image=http%3A%2F%2Fi1.sndcdn.com%2Fartworks-000229409224-qdgpk3-t500x500.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=soundcloud" width="800" height="166" frameborder="0" scrolling="no"><a href="https://medium.com/media/ea3ab3d0e52d64fa411ea9f16601d644/href">https://medium.com/media/ea3ab3d0e52d64fa411ea9f16601d644/href</a></iframe><p>Part 2:</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fw.soundcloud.com%2Fplayer%2F%3Furl%3Dhttp%253A%252F%252Fapi.soundcloud.com%252Ftracks%252F329474762%26show_artwork%3Dtrue&amp;url=https%3A%2F%2Fsoundcloud.com%2Fuser-119048141%2Fdavid-vivero-amino-meeting-1&amp;image=http%3A%2F%2Fi1.sndcdn.com%2Fartworks-000230001908-9xbpze-t500x500.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=soundcloud" width="800" height="166" frameborder="0" scrolling="no"><a href="https://medium.com/media/668ec10fe563928b17f9193b11fec08a/href">https://medium.com/media/668ec10fe563928b17f9193b11fec08a/href</a></iframe><p><em>Prefer to listen on iTunes? You can find the Future of Health </em><a href="https://itunes.apple.com/us/podcast/the-future-of-health/id1243930008?mt=2"><em>here</em></a><em>. (And please leave a rating and review while you’re there!</em></p><p>A lot of entrepreneurs take the lessons and — if all went well — proceeds from their companies after exiting and put them back into a new idea. Serial entrepreneurship, as they say. That’s basically <a href="https://www.crunchbase.com/person/david-vivero#/entity">David Vivero’s</a> story. He sold a tech startup to Zillow, where he then worked as an exec. When it was time to move on he knew he was going to start another company.</p><blockquote>“That whole beautiful benefits experience you had, you’re kind of on your own now.”</blockquote><p>Where his story differs is that the idea for his next venture — which turned into <a href="http://amino.com/">Amino</a> — came from the one-page COBRA document he received on leaving Zillow. The lack of transparency was frustrating. Also, it was kind of a lonely experience being out from under the employer’s umbrella. “That whole beautiful benefits experience you had, you’re kind of on your own now.”</p><p>So, he took what he calls a “tour” through the healthcare system, which for him revealed two issues complicating the process:</p><blockquote>“One, I was alone. COBRA is your first taste of not dealing with your employer directly…but I had a unique case because I had a unique condition and wasn’t able to get insurance on the individual market as an alternative.”</blockquote><p>Here is another place where David’s story differs from many. He had an entrepreneurial mindset and decided that this was where his next startup would come from. Zillow was built on transparency and helping consumers make better decisions, so why not take that background and translate it into healthcare?</p><blockquote>“Healthcare has become more than just a health issue. It’s a personal finance category.”</blockquote><p>From there, it was a matter of going from the superficial problem — consumers struggling to understand their coverage and care options — and doing what David considers the foundation of entrepreneurship: “fundamentally understanding a problem and discovering something that’s already there.”</p><p>In this case, the lack of transparency was only part of it. The deeper issue was (is) that “Healthcare has become more than just a health issue. It’s a personal finance category.”</p><blockquote>“We’ve always been viewed as passengers on this ship, not captains of our own vessels.”</blockquote><p>When looked at through that lens, the way people think about healthcare can change. But the problem, as David sees it, is that healthcare hasn’t engendered the trust we see in other industries. He pointed out that if you’re booking a flight, you have an airline you probably check first. If you’re designing a vacation, you have a travel website you look through. Looking for a doctor…not so much. And the reason for that is because we patients have had little say in the matter. It’s been top down, dictated by the industry. “We’ve always been viewed as passengers on this ship, not captains of our own vessels.”</p><p>So now, Amino is trying to help set up healthcare the way other industries operate. The <a href="http://amino.com/">company’s platform</a> let’s people search for the best providers for a specific condition or treatment based on several factors including age, gender, location and insurance. There is also a tool to estimate the cost of a limited but growing number of procedures.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*0RevZ8A851tv0drDG0aWWw.png" /><figcaption>Estimated cost for a surgical ankle repair around Health:Further’s home base of Nashville</figcaption></figure><p>The point, David says, is that it’s not about trying to get people to spend more or make people make decisions out of fear. It’s about thinking of individuals making just another personal finance decision, and building trusted brands to help guide those decisions the way Expedia or Kayak do for travel:</p><blockquote>“Our perspective is that every market deserves an independent, convenient, unbiased resource that helps people transact and feel good about the decisions they’re making.”</blockquote><p>It’s important to note that not all of this comes down on “the industry.” David notes that consumers have had access to “all you can eat” healthcare in the past, where we patients had little incentive to avoid more testing and more treatment. So tools like Amino were neither “possible nor necessary” a decade ago. Today, thanks to financial necessity and technological advances, better consumer resources have become both.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d264882d2346" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/the-future-of-health-ep-7-d264882d2346">David Vivero | Amino | Meeting People Where They Are</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism, June 14]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-june-14-33cc685a6136?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/33cc685a6136</guid>
            <category><![CDATA[diversity]]></category>
            <category><![CDATA[health-technology]]></category>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 14 Jun 2017 20:14:46 GMT</pubDate>
            <atom:updated>2017-06-14T20:14:46.273Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*FT1_rwBXTshMghnRuSu4Zg.png" /></figure><p>I heard a rumor that some of you are, um, a bit perplexed by at least one of the speakers coming to Health:Further this August.</p><p>Well, not a rumor. It’s in my inbox, straight from the aggrieved party. The sample size is small, but usually the number of people thinking a certain thing is something like an order of magnitude or two higher than the number of people saying that thing out loud. (Also, 87% of statistics are made up on the spot.)</p><p>Either way, it has been brought to our attention that not everyone agrees with the perspectives, biases, professional histories, or ideologies of everyone speaking at the Festival.</p><p>Normally, I’d brush of the critique because, well, you can never get everyone to agree on something. (Except the moon landing, right? We all know that was faked… kidding, kidding.)</p><p>But in this case the criticism reminded us here at Health:Further that we need to address the underlying point, and should have regardless of whether or not someone took the time to write a well-crafted email that included more than just two cents.</p><p>The point is that when we talk about an open community here at Health:Further…we mean it.</p><p>This can be hard to accept, I know. (No, for once I’m not being sarcastic, it really is hard.) We all have at least a few strongly held positions that come from a lot of careful consideration and, often, personal experience. And by definition we hold opinions because we think they’re right, which means people who disagree are wrong. Add in the hyper-politicized climate of 2017 (and ’16, and…), and it’s kinda hard to set aside our opinions, or even trust that people with opposing ideas are coming at it in good faith.</p><p>But...</p><p>We are doing Health:Further in good faith. Does that sound a little defensive? yes. Because I’m defending something that we are working very intentionally to do. And we’re working from the assumption that people in this community are also coming at it in good faith. We have to. We have literally set Health:Further up as “an open community focused on the future of health.” We are an organization that is not trying to create or provide the fixes for a broken system, but to offer a place for people with ideas for fixes to work on them and talk about them.</p><p>So, “debating in good faith” is the unspoken (not anymore) mandate of our organization. Speaking for myself, anyway, it feels damn near impossible these days to have respectful discussions among people with opposing viewpoints. But we can; at least, that’s our working hypothesis.</p><p>This discussion around the future of health — our way of saying, “fixing a badly busted system”— has to include a broad range of people and ideas. It’s diversity, not for the sake of saying, “hey look! We are a diverse community!” but for the sake of putting as many ideas as possible in one huge bucket, sorting through them and figuring out which ones are good, which ones are crap, which ones might work, which ones probably won’t…and then providing a place for people put the good ones together and create solutions.</p><p>Obviously there will always be biases that come into play, we’re all human. But “good idea” and “what works” should not be translated as “idea I agree with” and “fits my ideology.” That’s not diversity, that’s…whatever the opposite is.</p><p>Not everyone is going to agree and that’s fine. Just to be clear, if you come to Nashville for the Festival this August 22–25 expecting to nod along with the several dozen speakers and panelists, you’re going to be disappointed. You will not be on board with everyone.</p><p>I can say this with certainty because I am not on board with everyone. Other people on the team are not on board with the views of all our speakers. And that’s not unidirectional. There are people on our team who are ecstatic about certain speakers who I think are flat wrong on big issues, and vice versa.</p><p>Even aside from ideology I’d like to think our team is reasonably diverse. We have someone from Nebraska farm country who is steeped in design thinking, a self-taught developer from Brooklyn, a small-town Indianan MBA, and a cell biologist from Denver. That’s…kinda weird combination when it’s all written out. And yet we’re getting stuff done. Not in spite of, but largely because of the fact that we’re coming at this problem from a bunch of different perspectives.</p><p>We can’t just pay diversity lip service. Either we are diverse or not. And since we are, we’re going to welcome people with opposing viewpoints. We will trust that the people joining us is this absurdly difficult but exciting and necessary effort are ready to be challenged in their thinking and participate (in both “conversations” with individuals and “The Conversation”) with respect, honest and optimism.</p><p>With that expectation, we can all show up in August (and before, here on Medium and on the podcast and wherever else) open to being challenged. I can’t wait, but also a little nervous because I know I’m going to hear talks and have conversations that grind my gears. Having followed health and healthcare for a long time but being new to the community on a professional level, this will be the first time I get deep in the weeds. But that’s on me. It’ll be good, I need to be challenged in my thinking. Hope you all feel the same, and can’t wait to see you there.</p><p>Oh, and one more thing. If the person who wrote that email is reading this, and I kinda doubt you are, um…yeah, no. Don’t worry. Despite your concerns about us and our speaker selection, we’re not going to start telling you that vaccines cause autism. That’s not opinion, that’s fact.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=33cc685a6136" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-june-14-33cc685a6136">Healthy Optimism, June 14</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism, May 31]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-may-31-986fe72f8286?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/986fe72f8286</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[life-sciences]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 31 May 2017 19:49:46 GMT</pubDate>
            <atom:updated>2017-05-31T20:19:25.129Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*s0gYXKh3Q1IqndBtA2-HhA.png" /></figure><p>A scientist walks into a healthcare company…</p><p>In case it’s not clear by my bio and the material I choose to cover here on Healthy Optimism, I like the life sciences. I’m, um, not actually a healthcare guy. I mean, it’s headed that direction but my background is basic research. Cell biology. Intestinal physiology. And a hint of microbiology. I’m nerdy enough that, during my time in lab, I developed an attachment — a friendship, almost — with a couple of of high-end microscopes. Come to think of it that’s probably not nerdy, just socially maladjusted. Whatever.</p><p>Point is, I’m coming at this health and healthcare thing from a very different perspective than a lot of people in the business, including my colleagues. And being a scientist in a healthcare town, which Nashville definitely is, part of that perspective is shaped by the discovery of a strange but somewhat understandable line that’s artificially dividing two groups.</p><p>The line has been drawn between the life sciences and healthcare. On one side, anchoring the edge you have basic academic research. Molecular biology and the stuff I did. Further in you have pharma, small molecules, biologics, and genomics. Right near the center are medical devices and diagnostics. On the other side out at the edge you’ve got the business and finance of healthcare, including payers. Health IT and the infrastructure underlying the whole system, like EHRs, probably fits just a little closer in. Then there’s health tech and consumer devices, followed by the data analytics that personalized medicine relies on closest to the center line. Or something like that. I’m still figuring out exactly where it sits, which is part of the problem. It’s arbitrary.</p><p>The thing is, when you quit looking at “healthcare” and “life sciences” and instead look at the sub categories like “molecular biology” and “personalized medicine” and “genomics” and “diagnostics,” the line starts looking blurry at best, pointless at worst. If we don’t figure out that this whole thing is a (very long) continuum and not separate categories, we’re going to miss out on some crazy cool innovation in the future. Biology and silicone are coming together faster than anyone anticipated, and we have to figure out how to integrate the pieces to make it accessible and sustainable.</p><p>Caveats before going further.</p><p>First, yes, there are distinctions between “healthcare” and “life sciences” when you look at the extremes. Nobody would conflate the work I did in grad school on mouse intestinal cells with the work people do figuring out the financial modeling behind insurance plans.</p><p>Second, yes, there are — as Jumpstart Foundry CEO Vic Gatto has patiently explained to me on multiple occasions —solid business/VC reasons for drawing a line. Funding a health tech startups, or even a diagnostics company, is a very different proposition than putting money behind a team working on a biologic.</p><p>Aside from those caveats, though (fully admitting the handwaving that’s going on right here to just brush them off), the distinction between life sciences and healthcare is becoming burdensome and obsolete. The two industries are merging, largely because of the molecular revolution and its aftermath. We still don’t really understand how genetic information, including RNA as well as DNA, not to mention environmental and other triggers, lead to physiological changes. I mean, in some cases we do, but the field is still in its infancy. But what we do know is changing medicine. We can profile tumors to determine whether a given patient might respond better to one drug over another. We are starting to understand how the presence (or absence) of bacteria in our bodies is correlated with, if not causative of, everything from GI issues to obesity to neurological conditions. Diagnostics and a lot of medical devices are also rooted in molecular and cellular processes, whether or not they’re listed on the product fact sheet.</p><p>What ends up happening is that our molecular understanding of human biology informs and helps interpret the expanse of health data being collected, and vice versa, crossing over whatever line still exists.</p><p>This all seems obvious on paper, but in practice it seems like scientists and healthcare industry insiders don’t always know what to do with each other. Part of it is a failure by scientists to clearly explain how basic academic research leads in the long (and sometimes short) term to advances in human health. Part of it is due to the massive amount of energy the healthcare industry has to spend these days trying to figure out how to make the numbers work. There’s so much focus on the business of healthcare that it’s easy to forget about the science behind health.</p><p>Not sure if I’m communicating these thoughts well, even though this is a problem I spend a lot of time thinking about. It’s encouraging, though, to see progress. For all the handwringing around Theranos (of which I have taken part to an almost obsessive extent), it offers a good look at the merging of Silicon Valley, biology, and healthcare. Mistakes (or worse) were made, so let’s take the lessons and move on. Synthetic biology is moving fast, bringing engineering principles to biology to design molecular solutions to all kinds of problems that include issues of health. Diagnostics and medical devices are integrating new information from the scientific community and are being implemented in ways that are improving healthcare delivery — i.e., making the business of healthcare better.</p><p>I’m excited because here at Health:Further we’re working hard to figure out where that line is, why it exists, and how it can be removed. Our new partnership with Life Science Tennessee is both an indication of this commitment and a major part of the solution. We want more scientists at Health:Further to 1) talk about how their work affects human health and 2) learn about the realities of our health system. Or to flip it around, we want traditional healthcare types at Health:Further to 1) talk about the business of healthcare (an issue idealistic scientists can forget) and 2) learn more about innovation taking place at the molecular level that will change their businesses.</p><p>As we constantly say around here, “building the ideal future of health is going to take all of us.” It’s natural and necessary to draw some lines, we all need to define the terms and put constraints in place. Still, there’s no reason not to move the lines, adjust the constraints, to include as many relevant perspectives as possible. Especially when those lines don’t make sense anymore.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=986fe72f8286" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-may-31-986fe72f8286">Healthy Optimism, May 31</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism, May 17]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-may-17-fd7d7d76d263?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/fd7d7d76d263</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[ransomware]]></category>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[healthcare-it]]></category>
            <category><![CDATA[security]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 17 May 2017 12:40:30 GMT</pubDate>
            <atom:updated>2017-05-17T12:42:03.879Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3wgfEzesgJm5aN-3b76tyQ.png" /></figure><p>Soooo…bad week for the UK and National Health Service, huh? Appointments cancelled, <a href="http://www.fiercehealthcare.com/privacy-security/ransomware-attack-shuts-down-nhs-hospitals-as-malware-spreads-across-12-countries">imaging systems shut down</a>, repairs that could take weeks. Yay ransomware.</p><p>It used to be a handful of dudes wearing bandanas and carrying shotguns, jumping from behind rocks to hold up the Wells Fargo wagon. Now, it’s clever strings of code designed to lock down a user’s computer until they pay up. Same story, different generation.</p><p>And it’s not just health systems suffering. Telefonica, the communications company, was hit as well. Comcast was down for hours on Monday afternoon (including in Nashville, leading to a slightly earlier-than-normal happy hour in the Health:Further office). We didn’t quite get around to blaming WCry, but definitely had some fun speculating on what was happening. All told, as of the 12th, <a href="http://https//blog.avast.com/ransomware-that-infected-telefonica-and-nhs-hospitals-is-spreading-aggressively-with-over-50000-attacks-so-far-today">Avast</a> had seen 57,000 instances of the WannaCry ransomware attack across 99 countries. Three days later, according to an update, those numbers were 213,000 and 112, respectively.</p><p>This type of stuff? It’s only going to get worse. Ransomware attacks are on the rise. Earlier this year Forbes contributor Lee Mathews <a href="http://https//www.forbes.com/sites/leemathews/2017/02/07/2016-saw-an-insane-rise-in-the-number-of-ransomware-attacks/#4affbbda58dc">quoted data</a> showing a 19% increase in attacks from 2014 to 2015, and 16,800% from 2015 to 2016 (ok, it’s not quite that bad. It’s actually only 16,789.47%). Matthews also pointed out that setting up an attack has gotten pretty freaking easy, what with the new ability to subscribe to a ransomeware service called <a href="http://https//www.forbes.com/sites/leemathews/2017/01/12/spora-is-the-highly-sophisticated-future-of-ransomware/#528549233101">Spora</a>.</p><p>And so, we all sit around, pointing fingers at the NHS and the National Security Agency (which apparently built part of the WCry code), hoping that the hospital system where our medical records are housed isn’t next.</p><p>A lot of us…ok, fine, I’ll speak for myself. I tend to think, “why the crap aren’t people taking precautions?” A lot of the problem, according to analysts, is that Microsoft’s fix to close the hole exploited by WannaCry didn’t make it on to a lot of computers because <a href="http://https//www.ft.com/content/b25e5c5e-3a34-11e7-821a-6027b8a20f23">those computers were still running Windows XP</a>. So they couldn’t be updated. In fact, if you just search “windows xp,” the top hits are almost all about how, well, XP users should hunker down and get ready for the apocalypse.</p><p>Isn’t it worth doing to protect patient records and keep MRI machines up and running? I mean, we’re headed towards a world where EVERYTHING is linked through the Internet of Things. How much worse is it going to get as the hackers lock down our imaging scanners, our medical records, our personal information, and our <a href="http://www.samsung.com/us/explore/family-hub-refrigerator/">smart refrigerators</a>? So please, hospital administrators, just upgrade your systems, deal with the backlash, find some innovative vendors who can help you get past all that clunky legacy software, and keep our data safe.</p><p><em>(Plug for a friend — if you’re looking for vendors to help solve software or any other problems, check out </em><a href="http://https//app.lucro.com"><em>Lucro</em></a><em>. You post your need, the vendor posts their solution, you connect with each other and life gets a little better. And yes, Lucro is a Health:Further partner.)</em></p><p>Of course, it’s not that easy. People continue to run legacy systems because those systems run the software the users need, in the way they need it. Everything’s customized, finely tuned, balanced. Or at least generally functional. Why risk breaking something by upgrading? Plus, upgrading means getting all the users trained up with the new stuff. In healthcare, like so many other industries, the reaction to “we’re going to take a half day next Wednesday to teach you the new software management is installing,” is usually somewhere between an eye roll and white hot anger at the waste of precious billable time. Totally understandable, it’s a pain.</p><p>At the same time, we (ok, again, “I”) get all worked up when some faceless company emails to say my customer data has been compromised. And yet, I get irritated when I sign up for a new service and they push me to activate two-factor authentication. I mean, really? An extra step to logging in to my account? Why can’t I just type in my password “12345” and be done with it?</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2Fa6iW-8xPw3k&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Da6iW-8xPw3k&amp;image=http%3A%2F%2Fi.ytimg.com%2Fvi%2Fa6iW-8xPw3k%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/3ca0d368037a2f20837d7e87e77ef5f1/href">https://medium.com/media/3ca0d368037a2f20837d7e87e77ef5f1/href</a></iframe><p>Ask FBI Special Agent Scott Augenbaum. He gave a talk last week at the <a href="http://nexxus.appliedhealth.net/">Applied Health Analytics NEXXUS Conference</a> on cybersecurity in healthcare. Great talk. He spent most of his time, not yelling at big healthcare organizations and IT departments for mismanaging technology, but explaining why individual users are responsible for a huge chunk of the breaches he investigates. In fact, he said the one thing his victims all have in common is a failure to use two-factor authentication. Hackers get the password and there’s no recourse, no second layer of security to keep them out.</p><p>Once a hacker has an in to one user’s system or account, they can dig out contact information for other people, personal records, health information, and much more. He also noted that simple things like clicking links in emails or responding to phishing schemes can lead to system-wide problems. SA Augenbaum gave an example of a $5 million invoice that was paid to Nigerian scam artists instead of the vendor to whom it was owed. And then he told us about a similar incident where the damage was a mere $3.something million. Ooops.</p><p>In other words, while the headlines may come from the system wide attacks, the damage is often caused by small scale breaches caused by sloppiness on the part of individuals. In Augenbaum’s examples, it was nothing to do with firewalls or corporate regulations or — most notably — HIPAA. HIPAA has nothing to do with it, and it certainly won’t keep your organization safe from hackers if you and your team don’t protect your personal accounts.</p><p>So, as Augenbaum pointed out, it’s about prevention not recovery (sounds a lot like health in general, huh?). It means taking the time to do the little stuff — setting up two-factor authentication — and figuring out how to keep massive IT systems up to date without too much disruption. On the other hand, we’ve seen how much disruption software vulnerabilities can cause, so maybe the discomfort of changing out a legacy system isn’t so bad in comparison.</p><p>This is the weird dichotomy in healthcare. Things work well enough to get us by, but nowhere near well enough to match the minimum standards we’d expect for pretty much any other system or industry. Until the s**t hits the fan and people can’t get their MRIs or their personal information is being sold like a tourist trap t-shirt (3 for $10, 7 for $20, according to Augenbaum).Obviously, the WCry attack and many other problems show that healthcare isn’t the only industry with big gaps. But there’s a resistance to upgrading, innovating, switching course in healthcare that seems more pronounced than in most other industries. And, it’s both irritating and untenable. Unfortunately, it’s extreme events like the NHS attack that get people riled up. Fortunately, there are a lot of great people trying to figure out the solution to avoid the next catastrophe. Changes will happen, not just because they have to, but because really smart, good people want to make things better. Because some people like to create and do awesome things, not just make a couple bucks off my crappy password and general laziness.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=fd7d7d76d263" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-may-17-fd7d7d76d263">Healthy Optimism, May 17</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism — May 3]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-may-3-e0d4a264acce?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/e0d4a264acce</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[nih]]></category>
            <category><![CDATA[peer-review]]></category>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 03 May 2017 21:00:42 GMT</pubDate>
            <atom:updated>2017-05-04T13:37:41.211Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*EURr6OpVFadBeKA4vWlwcg.png" /></figure><h3>I’ll see your $1.7 billion and raise you $3.7 billion</h3><p>I once heard about a budget problem at a huge organization where some accountant forgot to include a minus sign in a spreadsheet somewhere. The error propagated from budget to budget over the course of years, until it was finally uncovered when an outside firm was hired to do a full audit of the organization’s finances.</p><p>Funny thing, the difference between +$50 million and -$50 million is, well, $100 million. Oops.</p><p>That story came to mind this week when Congress came out with its <a href="http://www.sciencemag.org/news/2017/05/how-science-fares-us-budget-deal">budget for the NIH and other science agencies</a>. At least in this case it went the other way. “Oh, you want a mins sign before that $1.7 billion? Yeah, we’ll just swap it out with a plus sign and round to the nearest billion.”</p><p>There’s a lot of great stuff in there, like $100 million for increased funding for the opioid crisis. Alzheimer’s and antibiotic resistance research also get significant bumps. Great stuff, assuming the money gets spent well. We’ll call it a win.</p><p>Of course, not everyone is happy. The White House, for one, <a href="http://https//www.wired.com/2017/05/congress-saved-science-budget-thats-problem/"><em>Wired Magazine</em></a>, for another. Adam Rogers at <em>Wired</em> makes some good points. “budgets are statements of priorities […and] If you really wanted to make a dent in quality of life and the incidence of disease, you’d focus on prevention.” He takes a subtle-ish shot at lobbyists (easy target, that) working for the pharmaceutical, hospital, health professional and health services industries. Look, we get it. Lobbying is bad when it goes against our preferred policies, a noble cause when aligned with our ideals (and, of course, in the latter case never called “lobbying.”) And yes, it would be great — in fact it’s critical — to get better policies in place around prevention and not just treatment. Heck, that’s a big part of the underlying premise of Health:Further. How do we make society healthier in the first place, before people need blood pressure meds and surgery?</p><p>Again, though, let’s take some wins where we can get them. It looks like the funding situation is far better, and far more of a compromise, than President Trump’s proposal. We’ll start there and then keep working on avoiding diabetes in the first place. We should also probably work on convincing the White House that even if cuts are necessary, a “<a href="http://https//www.forbes.com/sites/kennethdavis/2017/05/03/president-trumps-budget-should-boost-rather-than-cut-funding-for-the-nih/#740ed57a23fa">blunt budget ax</a>” isn’t the right approach. Even with funding apparently safe, <a href="http://www.dukechronicle.com/article/2017/05/duke-researchers-worry-about-potential-federal-budget-cuts-to-the-national-institutes-of-health-other-agencies">researchers are still understandably concerned</a> for the long-term outlook. Scientific and medical organizations are encouraging members to call their representatives to make sure the money doesn’t dry up and the increase goes through. Perfect stability doesn’t exist on this planet, but a little less uncertainty couldn’t hurt.</p><p>This saga is also a good reminder that, as important as the President is around here, there are still branches (plural) of government for checks and balances. Even if we’re not operating at optimum efficiency, we haven’t blown up yet.</p><p>— — —</p><p>It’s worth noting that, as of the moment this article is posted, Congress looks to be less than 24 hours away from <a href="http://www.businessinsider.com/ahca-obamacare-repeal-vote-count-upton-2017-5">voting on the Republican’s AHCA</a>. And Speaker Ryan has said publicly that he thinks he has enough votes to get it passed this time. We’ll wait to see what actually transpires before commenting further.</p><p>— — —</p><h3>With Imaginary Friends Like These…</h3><p>In other science-related news, there was an, um, unfortunate situation in the academic research world this past week. While tens of thousands of scientists across the globe were <a href="http://https//www.statnews.com/2017/04/22/march-for-science-rallies/">marching in support of science</a> and the value of actual data, an academic publisher was retracting over 100 papers for fraud. Oops.</p><p>When a lab submits a paper for publication, they also submit several names of people in the field qualified to review it and recommend publication, rejection or revision to the editor. So the goal is to find people who are honest and qualified, prepared to give a fair hearing to the work and not let politics or personal stuff get in the way. In short, when it’s used appropriately — and it usually is — peer review strengthens the research community and in the long run helps bring new advances to help patients.</p><p>In addition, peer-reviewed papers are the currency of the scientific community. More papers in better journals means more grant funding and better shots at coveted faculty positions and tenure. Publish or perish, as they say.</p><p>The problem is that alternative facts should have no place in science. Obviously. However, like any other field or industry, scientific research isn’t immune to malfeasance and negligence. Fake data or poorly-vetted data ends up in the cannon. Down the road, when translational researchers or pharma companies are looking through the literature for background on a new advance, that bad data contributes to sending them in the wrong direction. It’s not that a single bad paper is going to wreck development of a new cancer drug on its own, but the collective weaknesses in the historical dataset can cause problems. (There’s also the issue of a lack of reproducibility in science, but that’s a separate conversation.)</p><p>With that as background, here’s the <a href="http://retractionwatch.com/2017/04/20/new-record-major-publisher-retracting-100-studies-cancer-journal-fake-peer-reviews/">story</a>: Springer, one of the largest publishers in the world, pulled 107 papers from <em>Tumor Biology</em> a couple of weeks ago. Turns out that the peer review process the papers had undergone prior to publication was fake. Considering that peer review is the foundation on which the entire basic science edifice is built, this is kinda a big deal.</p><p>The authors (or a company hired by authors to help with the submission/acceptance process), submitted the names of real scientists but included email addresses that routed to other people. Some of the reviewers might have been completely faked, but that’s harder to pull off. Either way, the reviews came back positive — shocking! — and the papers were published. Imaginary friends for the win.</p><p>A big deal but not the first time it’s happened. This is just the largest haul of fake reviews found to date (the Retraction Watch article linked above is titled “A New Record”). Two other examples of mass retractions took place in <a href="http://https//www.washingtonpost.com/news/morning-mix/wp/2015/03/27/fabricated-peer-reviews-prompt-scientific-journal-to-retract-43-papers-systematic-scheme-may-affect-other-journals/?utm_term=.96c664f018fb">March</a> and <a href="http://www.nature.com/news/faked-peer-reviews-prompt-64-retractions-1.18202">August</a> of 2015 (43 and 64 papers, respectively), with the total suspected to be around 450.</p><p>Fortunately, when <em>Tumor Biology </em>and Springer found out about the problem a couple of years ago, they implemented new procedures to root out the offenders. Therefore, while this is concerning, it’s A) a tiny percentage of the papers that are published annually and B) a problem publishers and the honest scientific community are working to eliminate.</p><p>It’s definitely worth scientists being open about the issues of reproducibility and fraud (again, to be clear, those are two totally different issues) as they promote their work, extoll the virtues and benefits of research, and advocate for funding through events like the March for Science. Hopefully problems like this don’t create defensiveness but instead serve as a chance to educate the public on the scientific process and how real discoveries lead to innovations in health. Transparency is good.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e0d4a264acce" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-may-3-e0d4a264acce">Healthy Optimism — May 3</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[From Bench to…Somewhere]]></title>
            <link>https://medium.com/series/from-bench-to-somewhere-5ad0a3c4dfee?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/5ad0a3c4dfee</guid>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Sun, 23 Apr 2017 16:45:48 GMT</pubDate>
            <atom:updated>2017-04-23T16:45:48.605Z</atom:updated>
            <content:encoded><![CDATA[<p>Here are the things I think about a lot, in no particular order:</p><ul><li>What is “progress?”</li><li>Why does communication skill often seem to inversely correlate with level of technical training?</li><li>Is there more coffee?</li><li>How do we connect people and ideas?</li><li>What does innovation really mean?</li><li>I want food.</li><li>How do we use technology without losing the human touch?</li><li>That cookie looks delicious.</li><li>Health and science, the healthcare industry and academic research, are inextricably entwined. But they still don’t understand each other. That’s weird.</li><li>Are you going to finish that?</li><li>Compassion and social good aren’t mutually exclusive of making money and economic realities. But getting it right is hard.</li><li>What am I doing here?</li><li>It’s easy to conflate our preferred approach to a problem with THE approach.</li><li>Why am I eating this?</li><li>Data is data. It’s agnostic. But people are not. We are all idealogical. We all look at data and think it points to our preferred policy.</li><li>I have no clue what’s going on.</li></ul><p>Some of these things I’ve been thinking about for a long time. Others, I’m just now becoming aware of. All of them in some way affect how I go about my job and how I’ve wandered through the past few years. And so, I’ll try to write about it. Also, the cookie wasn’t nearly as good as it looked. But I ate it anyway. I always do.</p><p>My first mistake was walking in to the interview in a suit. Barely 21, a mere semester of cell culture and basic cloning under my belt (which was cinched tight around my scrawny waist to hold up the oversized suit pants), I thought you were supposed to wear a suit to a job interview.</p><p>My mistake became obvious when I walked into the cancer biology lab where I hoped to come on as an entry level tech. Jeans, t-shirts, and a lot of first-name informality in place of what I expected. I mean, I don’t know what I expected, but not this. All these people have PhDs, or are at least on their way to having them. Shouldn’t there be some kind of formal, title-based system and a hierarchy?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*aPBoyqTyEUcshR7APBJrmg.jpeg" /><figcaption>This is not accurate</figcaption></figure><p>The interview started with my prospective boss, who seemed in a big hurry (something I’d soon realize was baseline and not an aberration), rushing over to tell me…the interview wouldn’t be starting quite yet. She had to finish loading a gel.</p><p>Ah, yes, I had seen these gels. Thanks genetics class!</p><p>No, not a DNA gel. This one was for protein and, confusingly, ran vertically not horizontally.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*nLhnE-YHNWf0aIev3CiApA.jpeg" /><figcaption>DNA and protein: different things; DNA gels and protein gels: also different things</figcaption></figure><p>The scientists hurried back a few minutes later, stopped suddenly and looked hard at me (another thing that would soon become the norm). Really, I don’t remember anything after that.</p><p>Well, I do kind of remember walking out confused, at least as nervous as I had been walking in, and strongly considering stuffing my suit jacket into the nearest trash can. Pretty sure I got kind of lost trying to get out of the building, too.</p><p>Maybe a week later my prospective boss called. Much later I’d find out that there were only two applicants and the other guy showed up way late to his interview, so the suit ended up only the second biggest faux pas of the hiring process. I got the job.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5ad0a3c4dfee" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism — April 19, 2017]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-april-19-2017-10e765f8c388?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/10e765f8c388</guid>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[artificial-intelligence]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 19 Apr 2017 12:59:43 GMT</pubDate>
            <atom:updated>2017-04-19T12:59:43.253Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Q0T5EaEyct2xrJMemq570Q.png" /></figure><p>Well, it’s been a little bit quieter in the world of health these past couple of weeks. Quiet enough that it’s a chance to look at a non-acute item that keeps showing up in various forms across the web. More of an underlying theme than discrete events. There isn’t really an answer to the point, either. More just stuff we should be tracking (and yeah, for sure the healthcare industry is tracking) and, importantly, discussing here. So, if you have thoughts on anything, feel free to drop a comment and push back.</p><h3><strong>Open the Pod Bay Doors, Doc.</strong></h3><p>It’s the age-old question: AI or humans? Data, C3PO and Rosie are easy examples of artificial intelligence actually, you know, helping humans make things better (or in the case of C3PO, <em>trying</em> to help, but that’s a separate discussion). Then we have HAL, Terminator, Westworld Hosts*, Ava and certain politicians who are programmed to assist humans but in fact go rogue and, well, ruin things. Indeed, such is the danger of artificial intelligence that the entire Dune Universe is built on the elevation of human consciousness and the elimination of computer-based calculation.</p><p>Hang on, there’s a point to all this other than telling you that I got into sci fi later than most but am trying to make up for lost time.</p><p>It’s that artificial intelligence is coming to healthcare, in some regards is already here, and we have to figure out what to do with it. At its simplest, AI is building baseline algorithms that will allow the computer to accumulate new data, extract insights, and build better algorithms as a means to continuous improvement in health outcomes. Thus, we see companies taking the big data of human sequencing, finding mutations, linking them (or not) to disease states, and then repeating the process for more accurate and detailed diagnosis/prognosis. <a href="http://https//www.ibm.com/watson/health/oncology-and-genomics/genomics/">IBM</a> is using its lovable blue behemoth Watson to do this in oncology in partnership with Quest Diagnostics. A company here in Nashville called Faros Healthcare uses predictive analytics to both identify at-risk patients and treat them appropriately.</p><p>We also see AI and machine learning adding valuable depth to the day-to-day practice of medicine. <a href="http://https//praxify.com/">Praxify</a> layers on top of EHRs and learns how each individual physician user interacts with patient data, making it easier for providers to find and/or input the data they need. At the same time, Praxify looks at a patient’s record and extracts useful data, thereby helping clinicians to connect the dots and make better decisions.</p><p>The value? Faster and more accurate decision making, less time spent charting, and a simpler, more customized workflow. Translated that potentially means lower costs, better outcomes, better reimbursement (and/or fewer readmission penalties), and happier clinicians. Thanks HAL! (See what I did there? Because HAL was opposed to readmissions…? Nevermind.)</p><p>Robots are coming on line in the area of elder care, too, particularly in Japan. It’s companionship when people aren’t available, for whatever reason. Frankly, I tend to twitch a little when I see this. “A robot? I mean, I have quirky friends but Dinsow takes it to a whole new level.” At least we, um, don’t have to worry about Dinsow dropping us off at the Uncanny Valley.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F3csjRY8tGoI%3Ffeature%3Doembed&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D3csjRY8tGoI&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F3csjRY8tGoI%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/d9fc6a9cdda56f732571e24b8fffa5c7/href">https://medium.com/media/d9fc6a9cdda56f732571e24b8fffa5c7/href</a></iframe><p>On the other hand, if no one’s there and Dinsow makes people smile, interacting with elderly patients and improving quality of life. That can’t be bad, right…</p><h3><strong>Hollywood Ruins Everything</strong></h3><p>It all sounds great, but there may be a couple of issues. One is the fear played up by Hollywood: AI will get so good that those humanoid creations no longer need their creators and simply take over. Ok, so that’s overstating it, but the principle in healthcare is the same. Will AI get so good that providers are shoved aside and if so what then? Robots can’t replace the human touch, can they? We still need skin on skin contact, right?</p><p>In conversations with people in the Medical AI field, they all — without prompting — emphasize that they are not trying to build algorithms to replace clinicians. “Augment, not replace!” is the rallying cry. And it’s a compelling argument. Why not make it easier to find relevant information to move things along quicker? If anything, good AI in this context means providers can actually be more human, making more eye contact instead of poking at a glowing screen.</p><h3><strong>The Student Hasn’t (Quite) Surpassed the Master</strong></h3><p>The other issues is exactly the opposite of the first one. Can AI even meet or exceed the human brain? Look, let’s be real here. We still don’t know how the brain works. Yes, we have the <a href="http://www.cell.com/pictureshow/brainbow">Brainbow</a> and fMRI, and they (and other advances) have pushed us a long way in figuring out neuronal connections. But…it’s really freaking complicated. We haven’t come close to replicating the human brain, or building an AI system that can train itself to that level. Can we ever?</p><p>Westworld aside, intuition doesn’t seem like something we can build. “I don’t need a computer to tell me that!” our grandpas say. And it’s true. While some of us are sitting inside scrolling through the hourly forecast on our “smart”phones and looking for our umbrella, Grandpa is outside looking at the sky saying, “nah, it’s not gonna rain.” Who’s right more often?</p><p>Turns out, this is the case at times in medicine, too. Fierce Healthcare recently ran an <a href="http://www.fiercehealthcare.com/practices/as-good-as-algorithm-primary-care-docs-predict-likelihood-patient-hospitalization">article</a> highlighting a study in the <a href="http://www.ajmc.com/journals/issue/2017/2017-vol23-n4/Can-Primary-Care-Physicians-Accurately-Predict-the-Likelihood-of-Hospitalization-in-Their-Patients"><em>American Journal of Managed Care</em></a> that found that “Predictive accuracy of PCP assessment in our study (C statistic, 0.77; 95% CI, 0.75–0.79) was comparable to the reported C statistic of other commonly used risk stratification instruments.” In other words, primary care providers were just as good as computers at predicting which patients would end up back in the hospital. Why? Because they know their patients. That sort of etherial combination of individual patient data plus the personal understanding between patient and provider.</p><p>From there, the study says (in a quote highlighted in the Fierce article) “Given the predictive accuracy of PCPs’ clinical assessment, efforts to identify patients at high risk for future hospitalization should aim to incorporate the unique insight that PCPs have about predisposing biopsychosocial factors.”</p><p>It’s a pretty funny statement wrapped in academic-ese: “eh, we should probably look up from our computers and hear what the doctors have to say.” Put another way (is this taking it too far?), maybe gut feeling should officially become part of evidence-based practice.</p><p>Second example is from (where else) STAT News. A couple of weeks ago Kate Sheridan wrote up an article about a facial recognition program that can diagnose specific genetic conditions. Please read the whole thing, it’s a great article as always. The point here is that the algorithms used (maybe not technically AI) are still being dialed in and, in some cases only offer probabilities and not definitive, binary diagnoses. Experienced physicians, though, can “walk into a room and it’s like, oh, that child has Williams syndrome,” according to Dr. Maximilian Muenke, quoted by Sheridan. It’s the accumulation of knowledge over years, the conscious study and the unconscious observation of trends, that tell people instantly what’s happening.</p><h3><strong>Can’t We All Get Along?</strong></h3><p>Like I said at the top, I don’t know how this can or should play out. I’m a cell biologist, not a physician, ethicist**, computer scientist or even robot enthusiast. I do have a gut feeling that, while the Singularity is a cool hypothetical, our relationship with artificial intelligence may be more manageable than some people think. Start by focusing on how AI can augment our function as humans, the way Praxify and others are doing, instead of starting by trying to figure out what computers can do on their own. The human touch first, technology second.</p><p>Now please excuse me, I have to go rewatch <em>Blade Runner</em> before the sequel comes out.</p><p><em>*Ok, if we’re going to get technical, the hosts (spoiler alert) are in fact programmed to develop consciousness so technically they’re not going rogue.</em></p><p><em>**As I was finishing this post, an article came out in Aeon called “</em><a href="http://https//aeon.co/essays/creating-robots-capable-of-moral-reasoning-is-like-parenting"><em>Raising good robots.</em></a><em>” Not directly health-related, but a pretty cool discussion of if/how we can/should teach AI morals.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=10e765f8c388" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-april-19-2017-10e765f8c388">Healthy Optimism — April 19, 2017</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Healthy Optimism — April 5, 2017]]></title>
            <link>https://medium.com/healthfurther/healthy-optimism-april-5-2017-e9f69b71a0e0?source=rss-d2e3b011f3eb------2</link>
            <guid isPermaLink="false">https://medium.com/p/e9f69b71a0e0</guid>
            <category><![CDATA[drug-development]]></category>
            <category><![CDATA[healthfurther]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[obamacare]]></category>
            <category><![CDATA[healthcare-policy]]></category>
            <dc:creator><![CDATA[David Shifrin]]></dc:creator>
            <pubDate>Wed, 05 Apr 2017 15:30:59 GMT</pubDate>
            <atom:updated>2017-04-05T21:08:55.560Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vdesMsf7D4iJJWTcN9uY0Q.png" /></figure><p>Well, not much has happened in the past two weeks in the world of healthca…no wait, the complete opposite of that. As expected, as advertised, the new administration is providing plenty of…um, material for discussion around healthcare and the life sciences.</p><p>Add to the news about NIH funding a case study on why funding (from somewhere, anywhere, even if not the NIH) is desperately needed, and we have the makings of an interesting conversation around scientific R&amp;D.</p><p>Oh, and also, ACA repeal. In fact, let’s start there.</p><h3>So Many Acronyms, So Little Clarity</h3><p>A few weeks ago the Congressional Budget office scored the Republican Majority’s ACA alternative. The results led to a prophecy that 24 million people would lose coverage. Granted, the CBO can only score on assumptions within a bill and surrounding economic conditions and, well, we all know about assumptions. Conservative health policy analyst Avik Roy explained the potential problems with the 24 million number (and the CBO’s history with health insurance coverage projections) in a <a href="https://www.forbes.com/sites/theapothecary/2017/03/14/believe-it-or-not-cbos-score-of-house-gop-obamacare-replacement-is-better-than-expected/#65b5bff95951">detailed article at Forbes</a>.</p><p>There’s been plenty of number crunching to show serious problems with the American Health Care Act, though. Between sketchy, generally negative numbers and the bizarre realities of DC politics — pushback from both sides but for polar opposite reasons — House Speaker Paul Ryan pulled the bill from the floor. But we all already know that. What does it mean?</p><p>Great question and, like with so much of DC politics (see above), along with the risks of predicting the future (see above), we’re not going to go out on too much of a limb. There are few people who will, though. Many of these were posted before the bill collapsed, but they provide useful insight for the next attempt (which, Ryan assures us, <a href="https://www.washingtonpost.com/powerpost/paul-ryan-house-republicans-will-continue-their-push-for-health-care-reform-this-year/2017/03/27/8e331e86-130c-11e7-833c-503e1f6394c9_story.html?utm_term=.206f579c35f3">is going to happen</a>.)</p><p>The CBO’s numbers were plenty sufficient for the AMA and several patient advocate groups, which <a href="http://www.beckershospitalreview.com/hospital-management-administration/ama-urges-congressional-republicans-to-go-back-to-the-drawing-board-on-aca-repeal.html?utm_content=bufferae14c&amp;utm_medium=social&amp;utm_source=twitter.com&amp;utm_campaign=buffer">made it clear</a> that a bill leading to reductions in coverage was not going to get a thumbs up. And medical practitioners are getting fed up with dealing with the red tape of insurance, in general. A semi-scientific <a href="https://www.linkedin.com/pulse/insurance-driving-physicians-mad-nearly-half-now-say-theyd-kutscher">LinkedIn poll</a> recently showed that almost half of providers would be in favor of a single-payer system, even accepting lower financial reward in return for the chance to get back to spending time with patients. In other words, it appears that the medical community just wants to take care of people. Good idea, that.</p><p><a href="https://www.forbes.com/sites/sciencebiz/2017/03/24/how-the-american-health-care-act-could-affect-digital-health/#2276f50b13f1">People in the health tech space</a> noted that the AHCA would probably not have changed much as far as value-based care and MACRA. Better outcomes for lower costs are popular across the board. As a result, the need for ongoing innovation wasn’t going to change, even if the underlying financial environment did. And there, of course, is a great lesson for all times: keep creating and building, regardless of who holds the gavel.</p><p>On the payer side, <a href="http://www.healthcaredive.com/news/payers-could-bail-on-aca-exchanges-with-healthcare-reform-stalled/439129/">Healthcare Dive suggested</a> last week that the death of AHCA still leaves a lot of uncertainty around the existing ACA exchanges. Even with the status quo remaining, well, the status quo, it’s confusing enough that some insurers could “bail on ACA exchanges.” This problem ain’t going away, folks.</p><p>We could write for hours on ACA vs AHCA, Left vs Right, <a href="http://www.modernhealthcare.com/article/20170326/BLOG/170329933">winners and losers</a>. But, we have a meeting this afternoon and there’s other stuff going on in the world.</p><h3>No One Accused Him of Being Subtle</h3><p>…Like funding for research. And you thought we’d be leaving DC behind for the rest of this digest. Hah!</p><p>Hard to leave it behind when there are 1.2 billion reasons not to. That’s the $1.2 billion President Trump <a href="http://www.nbcnews.com/health/health-news/trump-proposes-slashing-medical-research-year-too-n739761">proposed cutting from the National Institutes of Health budget this year</a>, with almost $6 billion in cuts on the table for next year. The <a href="http://www.sciencemag.org/news/2017/03/trump-wants-2018-nih-cut-come-overhead-payments">primary target of cuts are indirect costs</a>, which are the funds research organizations take from scientists’ grants to pay for infrastructure. Literally, keeping the lights on. Only the future of research, and future advances in health, are at stake.</p><p>As with any budget, it’s Congress who sets the numbers, not the President. But the executive branch sets the tone, and a President’s budget is one of the most powerful ways to reveal an administration’s priorities. In this case, the White House is indirectly (see what we did there?) <a href="https://www.statnews.com/2017/03/29/tom-price-nih-budget/">presenting</a> the NIH cuts as part of the oft-repeated “waste and abuse” mantra.</p><p>It continues an interesting question about how funding affects spending. When more money is available to do [x], more of [x] will be done. Are there more efficient ways to do [x]? Maybe, but if the money is there to keep doing it the same way, will people be incentivized to find them? Thus, <a href="https://www.statnews.com/2017/03/31/nih-indirect-costs-universities/">as STAT points out</a>, proponents of the NIH cuts note private organizations that offer far less for indirect costs in their grants. Additionally, “Given [the size of university endowments], critics say, it makes little sense for taxpayers to foot the bill for lab utilities.”</p><p>On the other hand, scientists, science advocacy groups, and university administrations across the board have said that research will be devastated and some programs could shut down if the cuts go through. Someone has to keep the lights on.</p><p>As with the ACA/AHCA situation, the Administration is getting and will continue to get significant pushback from residents of both sides of the aisle.</p><p>Between the mind-numbingly frustrating overtures to the anti-vaccine community on the part of the Trump Administration (we try to be fair and open around here, but some ideas are just wrong and bad) and the proposed gouging of the NIH budget, scientists have just about had it. Plans are in the works for a massive <a href="https://www.marchforscience.com/">March for Science</a> on April 22 to remind our government of the importance of research in the pursuit of a healthy world. And yet, as in DC, there’s trouble brewing. <a href="https://www.statnews.com/2017/03/22/science-march/">According to STAT</a>, the event designed to present unity among the scientific community is anything but unified.</p><p>Regardless of policy and funding and marches and advocacy, really, how valuable is basic research? Well…</p><h3>A Long, Hard Road With a Wonderful Outcome</h3><p>…Pretty darn valuable, as it turns out. Not every scientific discovery makes it to human trials. In fact, only a tiny fraction of a percent do, according to a <a href="https://soundcloud.com/2scientists/designing-early-stage-clinical-trials">recent episode</a> of <a href="https://www.gene.com/stories/two-scientists-walk-into-a-bar">Genentech’s Two Scientists Walk Into a Bar Podcast</a>. But nothing makes it into human trials if no research is conducted.</p><p>We saw an amazing example of this recently when the <a href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm549325.htm">FDA approved Ocrevus</a>, the first drug built to treat Primary Progressive Multiple Sclerosis. It started in the ’70s, when Dr. Stephen Hauser jumped into research on B cells and showed that they’re involved in the aberrant immune response that causes inflammation and breakdown of the insulating sheath around nerve cells. For years, Hauser’s group carefully built a case for a drug to target B cells in the most severe cases of MS. They started from scratch in the lab, first proving the initial theory in an animal system that in and of itself took a decade to develop. From there, it was a long, slow slog to figure out the biological details and find a molecule to shepherd through the drug development process.</p><p>You can read more from <a href="https://www.ucsf.edu/news/2017/03/406296/new-multiple-sclerosis-drug-ocrelizumab-could-halt-disease">UCSF</a> (where Hauser is director of the Weill Institute for Neurosciences, and where much of the research was carried out) and <a href="https://www.statnews.com/2017/03/28/multiple-sclerosis-ms-drug-ocrelizumab/">STAT</a>.</p><p>It’s an outstanding story to remind us that, regardless of our political preferences, amazing work is going on across health and science and we must ensure that such work continues in an affordable and sustainable way.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e9f69b71a0e0" width="1" height="1" alt=""><hr><p><a href="https://medium.com/healthfurther/healthy-optimism-april-5-2017-e9f69b71a0e0">Healthy Optimism — April 5, 2017</a> was originally published in <a href="https://medium.com/healthfurther">Health:Further</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>